vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and SM Energy Co (SM). Click either name above to swap in a different company.
SM Energy Co is the larger business by last-quarter revenue ($704.9M vs $493.8M, roughly 1.4× Pediatrix Medical Group, Inc.). On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -17.3%). Over the past eight quarters, SM Energy Co's revenue compounded faster (12.2% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
SM Energy Company is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Denver, Colorado.
MD vs SM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $704.9M |
| Net Profit | $33.7M | — |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 25.9% |
| Net Margin | 6.8% | — |
| Revenue YoY | -1.7% | -17.3% |
| Net Profit YoY | 10.5% | — |
| EPS (diluted) | $0.40 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $704.9M | ||
| Q3 25 | $492.9M | $811.6M | ||
| Q2 25 | $468.8M | $792.9M | ||
| Q1 25 | $458.4M | $844.5M | ||
| Q4 24 | $502.4M | $852.0M | ||
| Q3 24 | $511.2M | $643.6M | ||
| Q2 24 | $504.3M | $634.6M | ||
| Q1 24 | $495.1M | $559.9M |
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $155.1M | ||
| Q2 25 | $39.3M | $201.7M | ||
| Q1 25 | $20.7M | $182.3M | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $19.4M | $240.5M | ||
| Q2 24 | $-153.0M | $210.3M | ||
| Q1 24 | $4.0M | $131.2M |
| Q4 25 | 9.9% | 25.9% | ||
| Q3 25 | 13.8% | 30.4% | ||
| Q2 25 | 12.8% | 37.2% | ||
| Q1 25 | 7.0% | 32.7% | ||
| Q4 24 | 7.8% | 33.7% | ||
| Q3 24 | 6.6% | 51.4% | ||
| Q2 24 | -31.3% | 44.0% | ||
| Q1 24 | 3.2% | 31.9% |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | 19.1% | ||
| Q2 25 | 8.4% | 25.4% | ||
| Q1 25 | 4.5% | 21.6% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 3.8% | 37.4% | ||
| Q2 24 | -30.3% | 33.1% | ||
| Q1 24 | 0.8% | 23.4% |
| Q4 25 | $0.40 | $0.94 | ||
| Q3 25 | $0.84 | $1.35 | ||
| Q2 25 | $0.46 | $1.76 | ||
| Q1 25 | $0.24 | $1.59 | ||
| Q4 24 | $0.37 | $1.63 | ||
| Q3 24 | $0.23 | $2.09 | ||
| Q2 24 | $-1.84 | $1.82 | ||
| Q1 24 | $0.05 | $1.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $368.0M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $4.8B |
| Total Assets | $2.2B | $9.3B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $368.0M | ||
| Q3 25 | $340.1M | $162.3M | ||
| Q2 25 | $224.7M | $101.9M | ||
| Q1 25 | $99.0M | $54.0K | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | $1.7B | ||
| Q2 24 | $19.4M | $487.9M | ||
| Q1 24 | $8.0M | $506.3M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $4.8B | ||
| Q3 25 | $890.7M | $4.7B | ||
| Q2 25 | $833.8M | $4.6B | ||
| Q1 25 | $789.2M | $4.4B | ||
| Q4 24 | $764.9M | $4.2B | ||
| Q3 24 | $732.5M | $4.1B | ||
| Q2 24 | $706.5M | $3.8B | ||
| Q1 24 | $856.2M | $3.7B |
| Q4 25 | $2.2B | $9.3B | ||
| Q3 25 | $2.2B | $9.1B | ||
| Q2 25 | $2.1B | $9.0B | ||
| Q1 25 | $2.0B | $8.8B | ||
| Q4 24 | $2.2B | $8.6B | ||
| Q3 24 | $2.1B | $8.0B | ||
| Q2 24 | $2.0B | $6.7B | ||
| Q1 24 | $2.2B | $6.4B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $451.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $451.9M | ||
| Q3 25 | $137.3M | $505.0M | ||
| Q2 25 | $137.2M | $571.1M | ||
| Q1 25 | $-117.5M | $483.0M | ||
| Q4 24 | $133.0M | $578.4M | ||
| Q3 24 | $91.8M | $452.3M | ||
| Q2 24 | $107.0M | $476.4M | ||
| Q1 24 | $-125.2M | $276.0M |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 3.26× | ||
| Q2 25 | 3.49× | 2.83× | ||
| Q1 25 | -5.66× | 2.65× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 1.88× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | -31.03× | 2.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SM
Segment breakdown not available.
